Predicted protein targets (top 18)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TNNC1 | P63316 | 6/20 | 0.43 |
| ▸ | S1PR1 | P21453 | 5/20 | 0.43 |
| ▸ | S1PR3 | Q99500 | 4/20 | 0.43 |
| ▸ | S1PR4 | O95977 | 3/20 | 0.43 |
| ▸ | S1PR5 | Q9H228 | 2/20 | 0.43 |
| ▸ | SGPL1 | O95470 | 1/20 | 0.43 |
| ▸ | GPR183 | P32249 | 1/20 | 0.43 |
| ▸ | CERS2 | Q96G23 | 1/20 | 0.43 |
| ▸ | MEN1 | O00255 | 1/20 | 0.41 |
| ▸ | LMNA | P02545 | 1/20 | 0.41 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.41 |
| ▸ | FDPS | P14324 | 3/20 | 0.40 |
| ▸ | ENPP2 | Q13822 | 1/20 | 0.40 |
| ▸ | S1PR2 | O95136 | 2/20 | 0.37 |
| ▸ | SPHK2 | Q9NRA0 | 2/20 | 0.37 |
| ▸ | SPHK1 | Q9NYA1 | 1/20 | 0.37 |
| ▸ | SMPD1 | P17405 | 2/20 | 0.33 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL141848 | 0.93 | MEN1 (0.47) | TNNC1S1PR1S1PR3S1PR4S1PR5 | |
| SCHEMBL1117541 | 0.88 | TNNC1 (0.48) | TNNC1S1PR1S1PR3S1PR4S1PR5 | |
| SCHEMBL1117297 | 0.88 | TNNC1 (0.44) | TNNC1S1PR1S1PR3S1PR4S1PR5 | |
| SCHEMBL1170515 | 0.87 | TNNC1 (0.52) | TNNC1S1PR1S1PR3S1PR4S1PR5 | |
| SCHEMBL1117709 | 0.86 | TNNC1 (0.52) | TNNC1S1PR1S1PR3S1PR4S1PR5 | |
| SCHEMBL1117507 | 0.86 | TNNC1 (0.52) | TNNC1S1PR1S1PR3S1PR4S1PR5 | |
| SCHEMBL1117411 | 0.86 | TNNC1 (0.52) | TNNC1S1PR1S1PR3S1PR4S1PR5 | |
| SCHEMBL1117435 | 0.86 | TNNC1 (0.52) | TNNC1S1PR1S1PR3S1PR4S1PR5 | |
| SCHEMBL1117539 | 0.86 | TNNC1 (0.52) | TNNC1S1PR1S1PR3S1PR4S1PR5 | |
| SCHEMBL1117587 | 0.86 | TNNC1 (0.52) | TNNC1S1PR1S1PR3S1PR4S1PR5 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20020136746-A1 | Cosmetic compositions comprising alk(en)ylsuccinic acid derivatives | CLARIANT GMBH | 2002-09-26 | — | — | US | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20020136746-A1 | Cosmetic compositions comprising alk(en)ylsuccinic acid derivatives | ALK, ALKBH3, ALKBH5 | TNNC1 4126/4885S1PR1 789/4885S1PR3 690/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.